Evidence for a central site of action to explain the negative chronotropic effect of atropine: studies on the human transplanted heart
AE Epstein,
BI Hirschowitz,
JK Kirklin,
KA Kirk,
GN Kay,
and
VJ Plumb
Department of Medicine, University of Alabama, Birmingham 35294.
The chronotropic response to atropine is biphasic; low doses cause slowing of the sinus rate and high doses cause acceleration. Although it is accepted that atropine functions as a competitive antagonist at high doses, the mechanism of the negative chronotropic response at low doses is controversial. Specifically, it is unclear whether the effect is mediated centrally or peripherally. Since at the time of cardiac replacement all central nervous system connections to the heart are severed, the transplanted heart is a unique model for separating these effects. Graded doses of atropine sulfate (0.5, 1.0, 2.0, 4.0, 8.0 and 40.0 micrograms/kg body weight) were administered to 12 human heart transplant recipients to test the hypothesis that the bradycardiac effect of low dose atropine is centrally mediated. The baseline sinus cycle lengths of the decentralized donor and innervated native sinus nodes were 694 +/- 20 and 733 +/- 27 ms, respectively. At the 0.5 and 1.0 microgram/kg doses, the cycle lengths of the native sinus node increased by 29.1 +/- 13.5 and 23.1 +/- 14.2 ms, respectively. At the 2.0 micrograms/kg dose the sinus cycle length again shortened to control. At the maximal dose of atropine the sinus cycle length shortened by 138.3 +/- 29.7 ms compared with control. In contrast, the decentralized donor sinus node exhibited a flat dose response to atropine. High dose atropine (40 micrograms/kg) caused no change in the donor heart's atrial effective refractory period, corrected sinus node recovery time, or sinoatrial conduction time measured by either the Strauss or the Narula method.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
|
|
 
C. O. Tan and J. A. Taylor
Does respiratory sinus arrhythmia serve a buffering role for diastolic pressure fluctuations?
Am J Physiol Heart Circ Physiol,
May 1, 2010;
298(5):
H1492 - H1498.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. Shi, D. W. Wray, K. J. Formes, H.-W. Wang, P. M. Hayes, A. H. O-Yurvati, M. S. Weiss, and I. P. Reese
Orthostatic hypotension in aging humans
Am J Physiol Heart Circ Physiol,
October 1, 2000;
279(4):
H1548 - H1554.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. H. Cooke, J. E. Ames IV, A. A. Crossman, J. F. Cox, T. A. Kuusela, K. U. O. Tahvanainen, L. B. Moon, J. Drescher, F. J. Baisch, T. Mano, et al.
Nine months in space: effects on human autonomic cardiovascular regulation
J Appl Physiol,
September 1, 2000;
89(3):
1039 - 1045.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O.-E. Brodde and M. C. Michel
Adrenergic and Muscarinic Receptors in the Human Heart
Pharmacol. Rev.,
December 1, 1999;
51(4):
651 - 690.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Montano, C. Cogliati, A. Porta, M. Pagani, A. Malliani, K. Narkiewicz, F. M. Abboud, C. Birkett, and V. K. Somers
Central Vagotonic Effects of Atropine Modulate Spectral Oscillations of Sympathetic Nerve Activity
Circulation,
October 6, 1998;
98(14):
1394 - 1399.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. L. Eckberg
Sympathovagal Balance : A Critical Appraisal
Circulation,
November 4, 1997;
96(9):
3224 - 3232.
[Full Text]
|
|
|
|
